Sedec Therapeutics Alternatives & Competitors
12 companies similar to Sedec Therapeutics — Leaders in protein palmitoylation pathway science.
Companies similar to Sedec Therapeutics
Tizona Therapeutics, Inc.
Harnessing the power of the immune system to develop treatments for cancer.
South San Francisco, Unit...
Immunaeon
Connecting Today's Science to Tomorrow's Cures
Buffalo, United States
SQZ Biotechnologies
Unlocking the full potential of cell therapies for patients around the world
Watertown, United States
Immutep Limited
The global leader in developing LAG-3 therapeutics (ASX: IMM, NASDAQ: IMMP)
Australia
Track all Sedec Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Achilles Therapeutics plc
Personalised T cell therapies targeting clonal neoantigens
United Kingdom
Bastion Therapeutics
Creating a future where inflammatory disorders are curable
London, United Kingdom
Applied Molecular Transport
We are committed to developing transformational biologic medicines to serve patients with...
South San Francisco, Unit...
Ranok Therapeutics
Discovering next-gen therapies through targeted protein degradation for safer and more eff...
Scarlet Therapeutics Ltd
We believe the future of medicine is in our blood.
Bristol, United Kingdom
Montis Biosciences
Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...
Belgium
Telo Therapeutics, Inc.
Deploying targeted protein degradation to unlock the full potential of nuclear transport i...
OSE Immunotherapeutics
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Nantes, France
About Sedec Therapeutics
Sedec Therapeutics, founded in 2021, is a pioneering company within the Biotechnology industry. Focused on breakthrough therapeutics, the firm emphasizes the modulation of the immune cell system specifically targeting autoimmune diseases and cancer immunotherapies. Leveraging advanced science in the protein palmitoylat...
Development of therapeutics for autoimmune diseases, Translating biological breakthroughs into therapeutic solutions
Healthcare organizations, Biopharmaceutical companies, Research institutions, Collaborative partners in the biotechnology industry
Protein Palmitoylation, Depalmitoylation Technology, Immune System Modulation, Autoimmune Disease Therapeutics, Cancer Immunotherapies, Biological Breakthroughs, Therapeutic Innovation, Pathway Science, Immune Cell System, Next-Generation Therapeutics, Biotech Innovations
B2B, B2B2C
Licensing, Product Sales, Performance Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Sedec Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Sedec Therapeutics on 11 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
